A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

890

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions

DeathMyocardial InfarctionCerebral Vascular AccidentHeart Failure Hospitalization

Interventions

BIOLOGICAL

Vitamin D3

Vitamin D3 (cholecalciferol) will be provided to participants of the study.

Trial Locations (1)

Intermountain Medical Center, Murray

All Listed Sponsors

lead

Intermountain Health Care, Inc.

OTHER